Posted Thu, Aug, 16,2012
Clinical Medicine Insights: Dermatology is an open access journal, meaning all articles are available for anyone to download freely without restriction. Open access journals are renowned for having high levels of article visibility compared to traditional subscription journals.
One good example of how open access journals can offer high visibility is 'Cosmeceutical Agents: A Comprehensive Review of the Literature', published in Clinical Medicine Insights: Dermatology. This article has been viewed more than 4,309 times since its publication in 2008. This is the highest rate of viewing of all articles in Clinical Medicine Insights: Dermatology and shows how publishing open access can increase article visibility and how publishing in Clinical Medicine Insights: Dermatology can offer higher levels of visibility than restricted access alternatives.
Authors publishing in Clinical Medicine Insights: Dermatology will benefit from the extensive indexing including many open access exclusive databases and directories that do not index subscription journals.
Visit the Clinical Medicine Insights: Dermatology most read articles list
Tue 21 May, 2013Article Reprint Service Available Now
Tue 21 May, 2013Review of Targeted Therapies for Advanced HCC
Tue 21 May, 2013Sequencing and Computing for Microbial Identification
My experience publishing in 'Clinical Medicine Insights: Oncology' was excellent. I was impressed with the quick review and proof-read processes. The electronic submission website is user friendly, and the continuous manuscript status updates received from the journal were helpful in tracking the progress of the paper.
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.See Our Results
Copyright © 2013 Libertas Academica Ltd (except open access articles and accompanying metadata and supplementary files.)